During the past decade, KEM Hospital conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 3 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "KEM Hospital" #1 sponsor was "Serum Institute of India Pvt. Ltd." with 2 trials, followed by "Abbott Nutrition" with 1 trials sponsored, "Bayer" with 1 trials sponsored, "Cubist Pharmaceuticals LLC" with 1 trials sponsored and "CymaBay Therapeutics, Inc." with 1 trials sponsored. Other sponsors include 1 different institutions and companies that sponsored additional 11 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "KEM Hospital" #1 collaborator was "PATH" with 2 trials as a collaborator, "CRO: JSS Medical Research India Pvt. Ltd." with 1 trials as a collaborator, "Centre for Cellular and Molecular Biology, Hyderabad, India" with 1 trials as a collaborator, "Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation" with 1 trials as a collaborator and "Russian Direct Investment Fund" with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were collaborators in the rest 5 trials.

According to Clinical.Site data, the most researched conditions in "KEM Hospital" are "Aneurysmal Subarachnoid Hemorrhage" (1 trials), "Breast Feeding" (1 trials), "COVID-19 Prevention" (1 trials), "Gaucher Disease, Type 1" (1 trials) and "Gestational Diabetes" (1 trials). Many other conditions were trialed in "KEM Hospital" in a lesser frequency.

Most popular intervention types in "KEM Hospital" are "Drug" (5 trials), "Other" (5 trials), "Biological" (4 trials) and "Device" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (5 trials), "Actos" (1 trials), "Clazosentan 15 mg/h" (1 trials), "Clazosentan 5 m/h" (1 trials) and "DTP-HB-Hib vaccine" (1 trials). Other intervention names were less common.

The vast majority of trials in "KEM Hospital" are 11 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "KEM Hospital". undefined are not yet recruiting, undefined are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 7 completed trials in KEM Hospital, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in KEM Hospital, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 1 trials that are defined as “Not Applicable".

KEM Hospital has several departments that took part in Clinical trials: "Diabetes Unit, Kem Hospital Research Centre" - 2 trials